About Citryll
Citryll is pioneering treatments for immune-mediated inflammatory diseases targeting Neutrophil Extracellular Traps with CIT-013.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B+
Global Headquarters
Oss, The Netherlands
Year Founded
2015
Team Size
11-50
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
citryll.com
Domain Registered Date
Sep 27, 2012
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $92,500,000 · Series-B+
fundraisingfox.com
- Capital Raise
Raised $20,879,100 · Series-B+
- Milestone
Company founded
Oss, The Netherlands
- Milestone
Website domain registered
citryll.com
Investors & Backers
BioGeneration Ventures
BOM
BrightGene
Curie Capital
Forbion Capital Partners
Johnson & Johnson Innovation
ModiQuest B.V.
Novartis Venture Fund
Pureos Bioventures
Seventure Partners
Funding History
Series-B+
· Dec 9, 2024
$92,500,000 fundraisingfox.com
Series-B+
· Jul 2, 2020
$20,879,100 Source
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026